ICMR and Panacea Biotec begin first pivotal dengue vaccine trial

Union Minister of Health and Family Welfare Shri Nadda said: “The initiation of this Phase III clinical trial for India’s first indigenous dengue vaccine marks a critical advancement in our fight against dengue. It reflects our commitment to protecting our citizens from this pervasive disease and underscores India’s capabilities in vaccine research and development.

“Through this collaboration between ICMR and Panacea Biotec, we are not only taking a step towards ensuring the health and well-being of our people but also reinforcing our vision of Atmanirbhar Bharat in the healthcare sector.”
הערה
20 percent up today
הערה
2 % up today
הערה
rocket
chartanalysisChart PatternsgoldpredictionTechnical IndicatorsinvestinglongopportunitylonterminvestmentmultibaggermultibaggerstockmultiyearbreakoutnewhighsTrend Analysis

כתב ויתור